We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 861

China Proposes Significant Changes to Its Import Drug Registration System
  • Sidley Austin LLP
  • China
  • March 20 2017

On March 17, the China Food and Drug Administration (CFDA) published a draft Decision for Adjusting the Administrative Regime for Import


American Health Care Act Moves Forward, Faces Challenges
  • Sidley Austin LLP
  • USA
  • March 15 2017

Now that the U.S. House of Representatives Energy and Commerce Committee and Ways and Means Committee have completed the markups of their respective


House Committee on Ways and Means Passes American Health Care Act After Markup
  • Sidley Austin LLP
  • USA
  • March 15 2017

The U.S. House of Representatives Ways and Means Committee began its markup of the American Health Care Act (AHCA) on the morning of March 8 and


Health and Human Services Secretary Dr. Tom Price Begins Building His Team, Tapping Several Capitol Hill Veterans
  • Sidley Austin LLP
  • USA
  • March 15 2017

The following individuals are expected to fill high-level positions at the U.S. Department of Health and Human Services (HHS), based on recent media


To Congress, President Trump Addresses Affordable Care Act, Prescription Drug Costs and Food and Drug Administration
  • Sidley Austin LLP
  • USA
  • March 15 2017

On Feb. 28, President Donald Trump outlined his administration's policy priorities during his first address to Congress. Among the topics he


House Energy and Commerce Committee Advances American Health Care Act After 27-Hour Markup
  • Sidley Austin LLP
  • USA
  • March 15 2017

On March 8 9, U.S. House of Representatives Energy and Commerce Committee member Republicans and Democrats faced off in a grueling, 27-hour markup of


House Health Subcommittee Holds Hearing on User Fee Program Reauthorizations and Generic Drug Competition Bill
  • Sidley Austin LLP
  • USA
  • March 15 2017

The U.S. House of Representatives Energy and Commerce Health Subcommittee held a hearing March 2 to consider reauthorization of the Food and Drug


Sen. Sanders Introduces Drug Importation Bill on Feb. 28
  • Sidley Austin LLP
  • OECD, USA
  • March 15 2017

On Feb. 28, Sen. Bernie Sanders, I-Vt., introduced S. 469, The Affordable and Safe Prescription Drug Importation Act, which would amend the Federal


Senate approves HHS secretary by party-line vote of 52 to 47
  • Sidley Austin LLP
  • USA
  • March 8 2017

On February 10 2017 the Senate approved Congressman Tom Price (R-GA) to be secretary of the Department of Health and Human Services (HHS) by a


FCA Case Against UnitedHealth Signals DOJ’s Continued Focus on MA Insurers and Coding Practices
  • Sidley Austin LLP
  • USA
  • March 6 2017

On February 16, 2017, the Department of Justice ("DOJ") intervened in a False Claims Act ("FCA") lawsuit against UnitedHealth Group, Inc